Chemical biology studies of the thalidomide binding domain of cereblon (Prof. Christina Woo)
The E3 ligase adaptor cereblon is a target of thalidomide and lenalidomide, therapeutic agents that are used in the treatment […]
The E3 ligase adaptor cereblon is a target of thalidomide and lenalidomide, therapeutic agents that are used in the treatment […]
Until now, many pathogens still carry a high disease burden and remain elusive to prevention by means of vaccination. New […]
Four years after giving his first-ever class, Prof. Bruno Correia, NCCR member and head of the EPFL’s Laboratory of Protein […]
Recently, work between the labs of Jérôme Waser and Beat Fierz (EPFL) was published in Chem: the paper describes a […]
Name: Claudio Zambaldo Current position: Scientist Place: F. Hoffmann La-Roche, Basel Field of work/Research topic: Small molecule lead generation and […]
Since its discovery in 2011, CRISPR/Cas9 is at the center of one of today’s most-discussed science discoveries: a technology that […]
This year Nobel Prize in Chemistry has been given to the power of directed evolution mainly applied to enzymes and […]
How can the use of small molecules and supramolecular assemblies lead to new therapeutics? This question is addressed in the […]